XML 34 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS | 12 Months Ended
--- | ---
Dec. 31, 2022
Insurance [Abstract] |
INSURANCE GROUP STATUTORY FINANCIAL INFORMATION | DAC AND OTHER DEFERRED ASSETS/LIABILITIES Changes in the DAC asset for the years ended December 31, 2022, and 2021 were as follows: December 31, 2022
| Protection Solutions |  | Individual Retirement |  |  | Legacy |  | Group Retirement |  | Corporate and Other | Total
| Term | UL | VUL | IUL |  | GMxBCore | EI | IE | SCS |  |  | GMxB Legacy |  | EG | Momentum |  | CB (1)
| (in millions)
Balance beginning of the year | $ | 385 |  | $ | 180 |  | $ | 799 |  | $ | 180 |  |  | $ | 1,653 |  | $ | 156 |  | $ | 121 |  | $ | 1,070 |  |  |  | $ | 631 |  |  | $ | 677 |  | $ | 94 |  |  | $ | 138 |  | $ | 6,084 |
Capitalization | 18 |  | 11 |  | 142 |  | 16 |  |  | 109 |  | 12 |  | 40 |  | 378 |  |  |  | 27 |  |  | 74 |  | 14 |  |  | — |  | 841 |
Amortization (2) | (41) |  | (12) |  | (52) |  | (11) |  |  | (137) |  | (12) |  | (13) |  | (169) |  |  |  | (65) |  |  | (41) |  | (19) |  |  | (11) |  | (583) |
Balance, December 31, 2022 | $ | 362 |  | $ | 179 |  | $ | 889 |  | $ | 185 |  |  | $ | 1,625 |  | $ | 156 |  | $ | 148 |  | $ | 1,279 |  |  |  | $ | 593 |  |  | $ | 710 |  | $ | 89 |  |  | $ | 127 |  | $ | 6,342 |
______________ (1) “CB” defined as Closed Block (2) DAC amortization of $3 million related to Other not reflected in table above. December 31, 2021
| Protection Solutions |  |  |  |  | Individual Retirement |  |  | Legacy |  | Group Retirement |  | Corporate and Other | Total
| Term | UL | VUL | IUL |  |  | GMxB Core | EI | IE | SCS |  |  | GMxB Legacy |  | EG | Momentum |  | CB (1)
| (in millions)
Balance beginning of the year | $ | 403 |  | $ | 177 |  | $ | 714 |  | $ | 162 |  |  |  | $ | 1,646 |  | $ | 154 |  | $ | 94 |  | $ | 855 |  |  |  | $ | 667 |  |  | $ | 634 |  | $ | 101 |  |  | $ | 150 |  | $ | 5,757 |
Capitalization | 26 |  | 15 |  | 133 |  | 28 |  |  |  | 141 |  | 15 |  | 38 |  | 350 |  |  |  | 30 |  |  | 84 |  | 16 |  |  | — |  | 876 |
Amortization (2) | (44) |  | (12) |  | (48) |  | (10) |  |  |  | (134) |  | (13) |  | (11) |  | (135) |  |  |  | (66) |  |  | (41) |  | (23) |  |  | (12) |  | (549) |
Balance, December 31, 2021 | $ | 385 |  | $ | 180 |  | $ | 799 |  | $ | 180 |  |  |  | $ | 1,653 |  | $ | 156 |  | $ | 121 |  | $ | 1,070 |  |  |  | $ | 631 |  |  | $ | 677 |  | $ | 94 |  |  | $ | 138 |  | $ | 6,084 |
______________ (1) “CB” defined as Closed Block (2) DAC amortization of $3 million related to Other not reflected in table above. Prior to the Company’s adoption of ASU 2018-12 effective January 1, 2021, changes in the DAC asset for the year ended 2020 were as follows:
|  |  |  |  | December 31,
|  |  |  |  | 2020
|  |  |  |  | (in millions)
Balance, beginning of year |  |  |  |  | $ | 5,840 |
Capitalization of commissions, sales and issue expenses |  |  |  |  | 669 |
Amortization: |  |  |  |  |
Impact of assumptions updates and model changes |  |  |  |  | (1,109) |
All other |  |  |  |  | (504) |
Total amortization |  |  |  |  | (1,613) |
Change in unrealized investment gains and losses |  |  |  |  | (654) |
Reclassified to assets HFS |  |  |  |  | 1 |
Balance, end of year |  |  |  |  | $ | 4,243 |
Changes in the Individual Retirement Sales Inducement Assets for the years ended December 31, 2022, and 2021 were as follows:
| December 31, 2022 |  | December 31, 2021 |  |  |
| GMxB Core |  | GMxB Legacy |  | GMxB Core |  | GMxB Legacy |  |  |
| ( in millions)
Balance beginning of the year | $ | 147 |  |  | $ | 222 |  |  | $ | 158 |  |  | $ | 246 |  |  |  |
Capitalization | 2 |  |  | — |  |  | 1 |  |  | — |  |  |  |
Amortization | (12) |  |  | (22) |  |  | (12) |  |  | (24) |  |  |  |
Balance, end of the year | $ | 137 |  |  | $ | 200 |  |  | $ | 147 |  |  | $ | 222 |  |  |  |
Changes in the Protection Solutions Unearned Revenue Liability for the years ended December 31, 2022, and 2021 were as follows:
| December 31, 2022 |  | December 31, 2021 |  |  |
| UL |  | VUL |  | IUL |  | UL |  | VUL |  | IUL |  |  |
| (in millions)
Balance beginning of the year | $ | 80 |  |  | $ | 619 |  |  | $ | 94 |  |  | $ | 60 |  |  | $ | 566 |  |  | $ | 24 |  |  |  |
Capitalization | 21 |  |  | 105 |  |  | 71 |  |  | 25 |  |  | 92 |  |  | 74 |  |  |  |
Amortization | (6) |  |  | (40) |  |  | (8) |  |  | (5) |  |  | (39) |  |  | (4) |  |  |  |
Balance, end of the year | $ | 95 |  |  | $ | 684 |  |  | $ | 157 |  |  | $ | 80 |  |  | $ | 619 |  |  | $ | 94 |  |  |  |
Prior to the Company’s adoption of ASU 2018-12 effective January 1, 2021, changes in the Sales Inducement Assets asset for the year ended 2020 were as follows:
|  |  |  |  | Year Ended December 31,
|  |  |  |  | 2020
|  |  |  |  | (in millions)
Balance, beginning of year |  |  |  |  | $ | 430 |
Amortization charged to income |  |  |  |  | (26) |
Balance, end of year |  |  |  |  | $ | 404 |
The following table presents a reconciliation of DAC to the consolidated balance sheet as of December 31, 2022, and 2021
| Years Ended December 31,
| 2022 |  | 2021 |  |
| (in millions)
Protection Solutions |  |  |  |  |
Term | $ | 362 |  |  | $ | 385 |  |  |
Universal Life | 179 |  |  | 180 |  |  |
Variable Universal Life | 889 |  |  | 799 |  |  |
Indexed Universal Life | 185 |  |  | 180 |  |  |
Individual Retirement |  |  |  |  |
GMxB Core | 1,625 |  |  | 1,653 |  |  |
EQUI-VEST Individual | 156 |  |  | 156 |  |  |
Investment Edge | 148 |  |  | 121 |  |  |
SCS | 1,279 |  |  | 1,070 |  |  |
Legacy Segment |  |  |  |  |
GMxB Legacy | 593 |  |  | 631 |  |  |
Group Retirement |  |  |  |  |
EQUI-VEST Group | 710 |  |  | 677 |  |  |
Momentum | 89 |  |  | 94 |  |  |
Corporate and Other | 127 |  |  | 138 |  |  |
Other | 27 |  |  | 29 |  |  |
Total | $ | 6,369 |  |  | $ | 6,113 |  |  |
Annually, or as circumstances warrant, we will review the associated decrements assumptions. (i.e. mortality and lapse) based on our multi-year average of companies experience with actuarial judgements to reflect other observable industry trends. In addition to DAC, the Unearned Revenue Liability and Sales Inducement Asset (“SIA”) use similar techniques and quarterly update processes for balance amortization. During the third quarter of 2022 and 2021, we completed our annual assumption update and the impact to the current period amortization of DAC and DAC like balances due to the new assumptions is immaterial. There were as no other material changes to the inputs, judgements or calculation processes used in the DAC calculation this period or year. LIABILITIES FOR FUTURE POLICYHOLDER BENEFITSThe following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts as of December 31, 2022 and 2021.
| December 31, 2022 |  | December 31, 2021 |  |  |
| Protection Solutions |  | Individual Retirement |  | Legacy | Corporate & Other |  | Protection Solutions |  | Individual Retirement |  | Legacy | Corporate & Other |  |  |  |  |  |  |
| Term |  | Payout |  | Payout | Group Pension |  | Health |  | Term |  | Payout |  | Payout | Group Pension |  | Health |  |  |  |  |  |  |  |  |
| (in millions) |
Present Value of Expected Net Premiums |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of year | $ | 2,485 |  |  | $ | — |  |  | $ | — |  | $ | — |  |  | $ | 22 |  |  | $ | 2,492 |  |  | $ | — |  |  | $ | — |  | $ | — |  |  | $ | 35 |  |  |  |  |  |  |  |  |  |
Beginning balance at original discount rate | 1,864 |  |  | — |  |  | — |  | — |  |  | 19 |  |  | 1,762 |  |  | — |  |  | — |  | — |  |  | 29 |  |  |  |  |  |  |  |  |  |
Effect of changes in cash flow assumptions | 204 |  |  | — |  |  | — |  | — |  |  | (10) |  |  | 69 |  |  | — |  |  | — |  | — |  |  | — |  |  |  |  |  |  |  |  |  |
Effect of actual variances from expected experience | 31 |  |  | — |  |  | — |  | — |  |  | (15) |  |  | 15 |  |  | — |  |  | — |  | — |  |  | (8) |  |  |  |  |  |  |  |  |  |
Adjusted beginning of year balance | 2,099 |  |  | — |  |  | — |  | — |  |  | (6) |  |  | 1,846 |  |  | — |  |  | — |  | — |  |  | 21 |  |  |  |  |  |  |  |  |  |
Issuances | 76 |  |  | — |  |  | — |  | — |  |  | — |  |  | 111 |  |  | — |  |  | — |  | — |  |  | — |  |  |  |  |  |  |  |  |  |
Interest accrual | 97 |  |  | — |  |  | — |  | — |  |  | — |  |  | 92 |  |  | — |  |  | — |  | — |  |  | 1 |  |  |  |  |  |  |  |  |  |
Net premiums collected | (194) |  |  | — |  |  | — |  | — |  |  | 1 |  |  | (185) |  |  | — |  |  | — |  | — |  |  | (3) |  |  |  |  |  |  |  |  |  |
Ending Balance at original discount rate | 2,078 |  |  | — |  |  | — |  | — |  |  | (5) |  |  | 1,864 |  |  | — |  |  | — |  | — |  |  | 19 |  |  |  |  |  |  |  |  |  |
Effect of changes in discount rate assumptions | 22 |  |  | — |  |  | — |  | — |  |  | — |  |  | 621 |  |  | — |  |  | — |  | — |  |  | 3 |  |  |  |  |  |  |  |  |  |
Balance, end of year | $ | 2,100 |  |  | $ | — |  |  | $ | — |  | $ | — |  |  | $ | (5) |  |  | $ | 2,485 |  |  | $ | — |  |  | $ | — |  | $ | — |  |  | $ | 22 |  |  |  |  |  |  |  |  |  |
| December 31, 2022 |  | December 31, 2021 |  |  |
| Protection Solutions |  | Individual Retirement | Legacy |  | Corporate & Other |  | Protection Solutions |  | Individual Retirement | Legacy |  | Corporate & Other |  |  |  |  |  |  |
| Term |  | Payout | Payout |  | Group Pension |  | Health |  | Term |  | Payout | Payout |  | Group Pension |  | Health |  |  |  |  |  |  |  |  |
| (Dollars in millions) |
Present Value of Expected Future Policy Benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of year | $ | 4,294 |  |  | $ | 1,114 |  | $ | 2,547 |  |  | $ | 683 |  |  | $ | 2,092 |  |  | $ | 4,475 |  |  | 1,158 |  | 2,250 |  |  | $ | 780 |  |  | $ | 2,334 |  |  |  |  |  |  |  |  |  |
Beginning balance of original discount rate | 3,241 |  |  | 883 |  | 2,400 |  |  | 632 |  |  | 1,915 |  |  | 3,184 |  |  | 883 |  | 1,993 |  |  | 686 |  |  | 2,028 |  |  |  |  |  |  |  |  |  |
Effect of changes in cash flow assumptions | 222 |  |  | (2) |  | (1) |  |  | — |  |  | (5) |  |  | 69 |  |  | 34 |  | 4 |  |  | (2) |  |  | — |  |  |  |  |  |  |  |  |  |
Effect of actual variances from expected experience | 31 |  |  | (1) |  | (4) |  |  | 1 |  |  | (13) |  |  | 11 |  |  | (8) |  | 9 |  |  | 1 |  |  | (4) |  |  |  |  |  |  |  |  |  |
Adjusted beginning of year balance | 3,494 |  |  | 880 |  | 2,395 |  |  | 633 |  |  | 1,897 |  |  | 3,264 |  |  | 909 |  | 2,006 |  |  | 685 |  |  | 2,024 |  |  |  |  |  |  |  |  |  |
Issuances | 82 |  |  | 23 |  | 758 |  |  | — |  |  | — |  |  | 117 |  |  | 26 |  | 490 |  |  | — |  |  | — |  |  |  |  |  |  |  |  |  |
Interest accrual | 168 |  |  | 40 |  | 63 |  |  | 21 |  |  | 61 |  |  | 168 |  |  | 40 |  | 61 |  |  | 23 |  |  | 65 |  |  |  |  |  |  |  |  |  |
Benefits payments | (353) |  |  | (98) |  | (192) |  |  | (71) |  |  | (163) |  |  | (308) |  |  | (92) |  | (157) |  |  | (76) |  |  | (174) |  |  |  |  |  |  |  |  |  |
Ending Balance at original discount rate | 3,391 |  |  | 845 |  | 3,024 |  |  | 583 |  |  | 1,795 |  |  | 3,241 |  |  | 883 |  | 2,400 |  |  | 632 |  |  | 1,915 |  |  |  |  |  |  |  |  |  |
Effect of changes in discount rate assumptions | 74 |  |  | (17) |  | (335) |  |  | (60) |  |  | (242) |  |  | 1,053 |  |  | 231 |  | 147 |  |  | 51 |  |  | 177 |  |  |  |  |  |  |  |  |  |
Balance, end of year | $ | 3,465 |  |  | $ | 828 |  | $ | 2,689 |  |  | $ | 523 |  |  | $ | 1,553 |  |  | $ | 4,294 |  |  | $ | 1,114 |  | $ | 2,547 |  |  | $ | 683 |  |  | $ | 2,092 |  |  |  |  |  |  |  |  |  |
Net liability for future policy benefits | $ | 1,365 |  |  | $ | 828 |  | $ | 2,689 |  |  | $ | 523 |  |  | $ | 1,558 |  |  | $ | 1,809 |  |  | $ | 1,114 |  | $ | 2,547 |  |  | $ | 683 |  |  | $ | 2,070 |  |  |  |  |  |  |  |  |  |
Less: Reinsurance recoverable | 21 |  |  | — |  | (465) |  |  | — |  |  | (1,242) |  |  | (42) |  |  | — |  | (143) |  |  | — |  |  | (1,641) |  |  |  |  |  |  |  |  |  |
Net liability for future policy benefits, after reinsurance recoverable | $ | 1,386 |  |  | $ | 828 |  | $ | 2,224 |  |  | $ | 523 |  |  | $ | 316 |  |  | $ | 1,767 |  |  | $ | 1,114 |  | $ | 2,404 |  |  | $ | 683 |  | $ | — |  | $ | 429 |  |  |  |  |  |  |  |  |  |
Weighted-average duration of liability for future policyholder benefits (years) | 7.0 |  | 9.5 | 8.1 |  | 7.2 |  | 8.7 |  | 7.5 |  | 9.6 | 8.4 |  | 7.2 |  | 8.9 |  |  |  |  |  |  |  |  |
The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheet as of December 31, 2022 and 2021.
| December 31, 2022 |  | December 31, 2021
| (in millions)
Reconciliation |  |  |
Term | $ | 1,365 |  |  | $ | 1,809 |
Individual Retirement - Payout | 828 |  |  | 1,114 |
Legacy - Payout | 2,689 |  |  | 2,547 |
Group Pension - Benefit Reserve & DPL | 523 |  |  | 683 |
Health | 1,558 |  |  | 2,070 |
UL and VUL - additional liability for death benefits | 1,109 |  |  | 1,087 |
subtotal | 8,072 |  |  | 9,310 |
W hole Life Closed Block and Open Block products | 5,664 |  |  | 5,911 |
Other (1) | 908 |  |  | 1,175 |
Future policyholder benefits total | 14,644 |  |  | 16,396 |
Other policyholder funds and dividends payable | 1,959 |  |  | 1,782 |
Total | $ | 16,603 |  |  | $ | 18,178 |
______________ (1)Primarily consists of Future policy benefits related to Protective Life and Annuity, Assumed Life and DI, GRP Life Run off, VISL rider and Employee Benefits. The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts as of December 31, 2022 and 2021:
| December 31, |  |
| 2022 |  | 2021 |  |
| (in millions) |  |
Term |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | $ | 6,022 |  |  | $ | 5,846 |  |  |
Expected future gross premiums (undiscounted) | 7,273 |  |  | 7,230 |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 3,465 |  |  | 4,294 |  |  |
Expected future gross premiums (discounted; AOCI basis) | 3,904 |  |  | 5,102 |  |  |
Payout - Legacy |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 3,947 |  |  | 3,066 |  |  |
Expected future gross premiums (undiscounted) | — |  |  | — |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 2,607 |  |  | 2,471 |  |  |
Expected future gross premiums (discounted; AOCI basis) | — |  |  | — |  |  |
Payout |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 1,460 |  |  | 1,538 |  |  |
Expected future gross premiums (undiscounted) | — |  |  | — |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 801 |  |  | 1,089 |  |  |
Expected future gross premiums (discounted; AOCI basis) | — |  |  | — |  |  |
Group Pension |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 730 |  |  | 797 |  |  |
Expected future gross premiums (undiscounted) | — |  |  | — |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 563 |  |  | 662 |  |  |
Expected future gross premiums (discounted; AOCI basis) | — |  |  | — |  |  |
Health |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 2,510 |  |  | 2,687 |  |  |
Expected future gross premiums (undiscounted) | 99 |  |  | 120 |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 1,533 |  |  | 2,052 |  |  |
Expected future gross premiums (discounted; AOCI basis) | $ | 78 |  |  | $ | 108 |  |  |
The tables below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts for the year ended December 31, 2022 and 2021:
|  | Gross Premium |  | Interest Accretion
|  | December 31, 2022 |  | December 31, 2021 |  |  | December 31, 2022 |  | December 31, 2021
|  | (in millions)
Revenue and Interest Accretion |  |  |  |  |  |  |  |  |
Term |  | $ | 275 |  |  | $ | 282 |  |  |  | $ | 70 |  |  | $ | 75 |
Payout - Legacy |  | 101 |  |  | 106 |  |  |  | 63 |  |  | 60 |
Payout |  | 22 |  |  | — |  |  |  | 40 |  |  | 40 |
Group Pension |  | — |  |  | — |  |  |  | 21 |  |  | 24 |
Health |  | 9 |  |  | 10 |  |  |  | 61 |  |  | 64 |
Total |  | $ | 407 |  |  | $ | 398 |  |  |  | $ | 255 |  |  | $ | 263 |
The following table provides the weighted average interest rates for the liability for future policy benefits as of December 31, 2022 and 2021:
|  |  | December 31,
|  |  | 2022 |  | 2021
Weighted Average Interest Rate |  |  |  |  |
Term Life |  |  |  |  |
Interest accretion rate |  |  | 5.7 | % |  | 5.8 | %
Current discount rate |  |  | 5.1 | % |  | 2.4 | %
Payout - Legacy |  |  |  |  |
Interest accretion rate |  |  | 3.4 | % |  | 3.1 | %
Current discount rate |  |  | 5.0 | % |  | 2.3 | %
Payout - Non-Legacy |  |  |  |  |
Interest accretion rate |  |  | 4.9 | % |  | 4.9 | %
Current discount rate |  |  | 5.2 | % |  | 2.6 | %
Group Pension |  |  |  |  |
Interest accretion rate |  |  | 3.4 | % |  | 3.4 | %
Current discount rate |  |  | 5.1 | % |  | 2.3 | %
Health |  |  |  |  |
Interest accretion rate |  |  | 3.3 | % |  | 3.3 | %
Current discount rate |  |  | 5.2 | % |  | 2.5 | %
Additional Insurance Liability The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities as of December 31, 2022 and 2021.
| December 31, 2022 |  | December 31, 2021 |  |
| Protection Solutions
| Universal Life |  | Universal Life |  |
| (Dollars in millions)
Balance, beginning of the period | $ | 1,087 |  |  | $ | 1,021 |  |  |
Beginning balance before AOCI adjustments | 1,076 |  |  | 1,005 |  |  |
Effect of changes in interest rate & cash flow assumptions and model changes | 8 |  |  | (4) |  |  |
Effect of actual variances from expected experience | 25 |  |  | 8 |  |  |
Adjusted beginning of the period balance | 1,109 |  |  | 1,009 |  |  |
Interest accrual | 49 |  |  | 45 |  |  |
Net assessments collected | 68 |  |  | 85 |  |  |
Benefit payments | (91) |  |  | (63) |  |  |
Ending balance before shadow reserve adjustments | 1,135 |  |  | 1,076 |  |  |
Effect of reserve adjustment recorded in AOCI | (26) |  |  | 11 |  |  |
Balance, end of the period | $ | 1,109 |  |  | $ | 1,087 |  |  |
Net liability for additional liability (1) | $ | 1,109 |  |  | $ | 1,087 |  |  |
Less: Reinsurance recoverable | — |  |  | — |  |  |
Net liability for additional liability, after reinsurance recoverable | $ | 1,109 |  |  | $ | 1,087 |  |  |
Weighted-average duration of additional liability - death benefit (years) | 22.0 |  | 23.2 |  |
The following table provides the revenue, interest and weighted average interest rates, related to the additional insurance liabilities for the years ended and as of December 31, 2022 and 2021.
|  |  | Assessments |  |  | Interest Accretion
|  |  | December 31, 2022 |  | December 31, 2021 |  |  |  | December 31, 2022 |  | December 31, 2021
|  |  | (in millions)
Revenue and Interest Accretion |  |  |  |  |  |  |  |  |  |  |
Universal Life |  |  | $ | 666 |  |  | $ | 850 |  |  |  |  | $ | 49 |  |  | $ | 45 |
Total |  |  | $ | 666 |  |  | $ | 850 |  |  |  |  | $ | 49 |  |  | $ | 45 |
|  |  | December 31,
|  |  | 2022 |  | 2021
Weighted Average Interest Rate |  |  |  |  |
Universal Life |  |  | 4.5 | % |  | 4.5 | %
Interest accretion rate |  |  | 4.5 | % |  | 4.5 | %
The discount rate used for additional insurance liabilities reserve is based on the crediting rate at issue. INSURANCE GROUP STATUTORY FINANCIAL INFORMATION In accordance with statutory accounting practices, the following table presents the combined statutory net income (loss), surplus, capital stock & AVR, and securities on deposits for Equitable Financial, Equitable America, USFL, Equitable L&A and CS Life.
| 2022 |  | 2021 |  | 2020 |
| (in millions) |
Years Ended December 31, |  |  |  |  |  |
Combined statutory net income (loss) (1) (2) | $ | 148 |  |  | $ | (936) |  |  | $ | 396 |  |
As of December 31, |  |  |  |  |  |
Combined surplus, capital stock and AVR | $ | 7,125 |  |  | $ | 6,864 |  |  |  |
Combined securities on deposits in accordance with various government and state regulations | $ | 17 |  |  | $ | 65 |  |  |  |
_____________ (1) For 2021, excludes CS Life which was sold June 1, 2021. (2) For 2020, excludes USFL which was sold April 1, 2020. In 2022 and 2020, Equitable Financial paid to its direct parent, which subsequently distributed such amount to Holdings, an ordinary shareholder dividend of $930 million and $2.1 billion, respectively. Equitable Financial did not pay ordinary dividends during 2021 due to operating losses. Dividend Restrictions As domestic insurance subsidiaries regulated by insurance laws of their respective domiciliary states, Equitable Financial and Equitable America are subject to restrictions as to the amounts they may pay as dividends and amounts they may repay of surplus notes to Holdings. State insurance statutes also typically place restrictions and limitations on the amount of dividends or other distributions payable by insurance company subsidiaries to their parent companies, as well as on transactions between an insurer and its affiliates. Under New York’s insurance laws, which are applicable to Equitable Financial, a domestic stock life insurer may not, without prior approval of the NYDFS, pay an ordinary dividend to its stockholders exceeding an amount calculated based on a statutory formula (“Ordinary Dividend”). Dividends in excess of this amount require the insurer to file a notice of its intent to declare the dividends with the NYDFS and obtain prior approval or non-disapproval from the NYDFS with respect to such dividends (“Extraordinary Dividend”). Due to a permitted statutory accounting practice agreed to with the NYDFS, Equitable Financial will need the prior approval of the NYDFS to pay the portion, if any, of any Ordinary Dividend that exceeds the Ordinary Dividend that Equitable Financial would be permitted to pay under New York’s insurance laws absent the application of such permitted practice (such excess, the “Permitted Practice Ordinary Dividend”). Applying the formulas above, Equitable Financial could pay an Ordinary Dividend of up to approximately $1.7 billion in 2023. Intercompany Reinsurance Equitable Financial and Equitable America receive statutory reserve credits for reinsurance treaties with EQ AZ Life Re to the extent EQ AZ Life Re holds assets in an irrevocable trust (the “EQ AZ Life Re Trust”). As of December 31, 2022, EQ AZ Life Re holds $1.7 billion of assets in the EQ AZ Life Re Trust and letters of credit of $2.1 billion that are guaranteed by Holdings. Under the reinsurance transactions, EQ AZ Life Re is permitted to transfer assets from the EQ AZ Life Re Trust under certain circumstances. The level of statutory reserves held by EQ AZ Life Re fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or additional letters of credit be secured, which could adversely impact EQ AZ Life Re’s liquidity. Prescribed and Permitted Accounting Practices As of December 31, 2022, the following three prescribed and permitted practices resulted in net income (loss) and capital and surplus that is different from the statutory surplus that would have been reported had NAIC statutory accounting practices been applied. Equitable Financial was granted a permitted practice by the NYDFS to apply SSAP 108, Derivatives Hedging Variable Annuity Guarantees on a retroactive basis from January 1, 2021 through June 30, 2021, after reflecting the impacts of our reinsurance transaction with Venerable. The permitted practice was amended to also permit Equitable Financial to adopt SSAP 108 prospectively as of July 1, 2021 and to consider the impact of both the interest rate derivatives and the general account assets used to fully hedge the interest rate risk inherent in its variable annuity guarantees when determining the amount of the deferred asset or liability under SSAP 108. Application of the permitted practice partially mitigates the New York Insurance Regulation 213 (“Reg 213”) impact of the Venerable Transaction on Equitable Financial’s statutory capital and surplus and enables Equitable Financial to more effectively neutralize the impact of interest rates on its statutory surplus and to better align with our economic hedging program. The impact of applying this permitted practice relative to SSAP 108 as written was an increase of approximately $86 million in statutory special surplus funds, a decrease of $1.3 billion in statutory net income for the year ended December 31, 2022 and an increase of $1.4 billion for the year ended December 31, 2021, which will be amortized over five years for each of the retrospective and prospective components. The permitted practice also reset Equitable Financial’s unassigned surplus to zero as of June 30, 2021 to reflect the transformative nature of the Venerable Transaction. The NAIC Accounting Practices and Procedures manual (“NAIC SAP”) has been adopted as a component of prescribed or permitted practices by the State of New York. However, Reg 213 adopted in May of 2019 and as amended in February 2020 and March 2021, differs from the NAIC variable annuity reserve and capital framework. Reg 213 requires Equitable Financial to carry statutory basis reserves for its variable annuity contract obligations equal to the greater of those required under (i) the NAIC standard or (ii) a revised version of the NYDFS requirement in effect prior to the adoption of the first amendment for contracts issued prior to January 1, 2020, and for policies issued after that date a new standard that in current market conditions imposes more conservative reserving requirements for variable annuity contracts than the NAIC standard. The impact of the application of Reg 213 was a decrease of approximately $1.9 billion in statutory surplus as of December 31, 2022 compared to statutory surplus under the NAIC variable annuity framework. Our hedging program is designed to hedge the economics of our insurance liabilities and largely offsets Reg 213 and NAIC framework reserve movements due to interest rates and equities. The NYDFS allows domestic insurance companies a five year phase-in provision for Reg 213 reserves. As of September 30, 2022, Equitable Financial’s Reg 213 reserves were 100% phased-in. As of December 31, 2022, given the prevailing market conditions and business mix, there are no Reg 213 redundant reserves over the US RBC CTE 98 total asset requirement (“TAR”). Finally, the continued application of Reg 213 resulted in a corresponding decrease of $0.7 billion in statutory net income for the year ended December 31, 2022, which was largely offset by net income gains on our hedging program during the same period as noted. During the fourth quarter 2020, Equitable Financial received approval from NYDFS for its proposed amended Plan of Operation for Separate Account No. 68 (“SA 68”) for our Structured Capital Strategies product and Separate Account No. 69 (“SA 69”) for our EQUI-VEST product Structured Investment Option, to change the accounting basis of these two non-insulated Separate Accounts from fair value to book value in accordance with Section 1414 of the Insurance Law to align with how we manage and measure our overall general account asset portfolio. In order to facilitate this change and comply with Section 4240(a)(10), the Company also sought approval to amend the Plans to remove the requirement to comply with Section 4240(a)(5)(iii) and substitute it with a commitment to comply with Section 4240(a)(5)(i). Similarly, the Company updated the reserves section of each Plan to reflect the fact that Regulation 128 would no longer be applicable upon the change in accounting basis. We applied this change effective January 1, 2021. The impact of the application is an increase of approximately $2.2 billion in statutory surplus and an increase in statutory net income for the year ended December 31, 2022 of $2.3 billion, respectively. Equitable Financial and Equitable America cede a portion of their statutory reserves to EQ AZ Life Re, a captive reinsurer, as part of the Company’s capital management strategy. EQ AZ Life Re prepares financial statements in a special purpose framework for statutory reporting. Differences between Statutory Accounting Principles and U.S. GAAP Accounting practices used to prepare statutory financial statements for regulatory filings of stock life insurance companies differ in certain instances from U.S. GAAP. The differences between statutory surplus and capital stock determined in accordance with SAP and total equity under U.S. GAAP are primarily: (a) the inclusion in SAP of an AVR intended to stabilize surplus from fluctuations in the value of the investment portfolio; (b) future policy benefits and policyholders’ account balances under SAP differ from U.S. GAAP due to differences between actuarial assumptions and reserving methodologies; (c) certain policy acquisition costs are expensed under SAP but deferred under U.S. GAAP and amortized over future periods to achieve a matching of revenues and expenses; (d) under SAP, Federal income taxes are provided on the basis of amounts currently payable with limited recognition of deferred tax assets while under U.S. GAAP, deferred taxes are recorded for temporary differences between the financial statements and tax basis of assets and liabilities where the probability of realization is reasonably assured; (e) the valuation of assets under SAP and U.S. GAAP differ due to different investment valuation and depreciation methodologies, as well as the deferral of interest-related realized capital gains and losses on fixed income investments; (f) the valuation of the investment in AB and AB Holding under SAP reflects a portion of the market value appreciation rather than the equity in the underlying net assets as required under U.S. GAAP; (g) reporting the surplus notes as a component of surplus in SAP but as a liability in U.S. GAAP; (h) computer software development costs are capitalized under U.S. GAAP but expensed under SAP; (i) certain assets, primarily prepaid assets, are not admissible under SAP but are admissible under U.S. GAAP; and (j) cost of reinsurance which is recognized as expense under SAP and amortized over the life of the underlying reinsured policies under U.S. GAAP.

X
- References No definition available. + Details
Name: | us-gaap_InsuranceAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -URI https://asc.fasb.org/topic&trid=2303980 + Details
Name: | us-gaap_InsuranceDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration